244 related articles for article (PubMed ID: 453214)
21. Rifampicin-isoniazid and delayed elimination of theophylline: a case report.
Dal Negro R; Turco P; Trevisan F; De Conti F
Int J Clin Pharmacol Res; 1988; 8(4):275-7. PubMed ID: 3182118
[TBL] [Abstract][Full Text] [Related]
22. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations.
Cova D; Cuglituri G; Rossini L; Bonfardeci G
Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):273-5. PubMed ID: 2737795
[TBL] [Abstract][Full Text] [Related]
23. Oral aminophylline and dikydroxypropyl theophylline in reversible obstructive airway disease: a single-dose, double-blind, crossover comparison.
Hudson LD; Tyler ML; Petty TL
Curr Ther Res Clin Exp; 1973 Jul; 15(7):367-72. PubMed ID: 4198297
[No Abstract] [Full Text] [Related]
24. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
Longo G; Poli F; Strinati R; Longo F
Pediatr Med Chir; 1984; 6(5):645-9. PubMed ID: 6535126
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
26. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
Gatto PG; Bruzzoni A; Valenti V
Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
[TBL] [Abstract][Full Text] [Related]
27. [The pharmacokinetic characteristics of theophylline in patients with chronic nonspecific intestinal diseases in relation to its routes of administration into the gastrointestinal tract].
Kukes VG; Fazylov AV; Kirkin BV; Kurapov AP; Blinov IL
Ter Arkh; 1993; 65(2):52-4. PubMed ID: 9133013
[TBL] [Abstract][Full Text] [Related]
28. [Bioavailability of a delayed-action aminophylline preparation].
Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
[TBL] [Abstract][Full Text] [Related]
29. [The effect of long-term oral administration of a bronchodilator, a sustained-release aminophylline preparation, on pulmonary function (author's transl)].
Wiessmann KJ
Dtsch Med Wochenschr; 1975 Nov; 100(48):2482-6. PubMed ID: 1201724
[TBL] [Abstract][Full Text] [Related]
30. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
Aamodt T; Lien JT; Haaversen O; Osmundsen K
Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
[No Abstract] [Full Text] [Related]
31. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
Riddington CJ; Shipman AJ
Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
[No Abstract] [Full Text] [Related]
32. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
Grassi V; Nicora M; Beretta A
Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
[TBL] [Abstract][Full Text] [Related]
33. The use of theophylline clearance to design an oral aminophylline regimen.
Simmons SM; Camp RB; Mungall DR; Bailey WC
Ala J Med Sci; 1982 Apr; 19(2):142-6. PubMed ID: 7102998
[No Abstract] [Full Text] [Related]
34. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
Hirsch H
Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
[TBL] [Abstract][Full Text] [Related]
35. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
Schulz HU; Steinijans VW; Gabel H
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
[TBL] [Abstract][Full Text] [Related]
36. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
Baronti A; Verdiani P; Di Carlo S
Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
[No Abstract] [Full Text] [Related]
37. Comparison of two sustained-release theophylline preparations in adult patients with obstructive airways disease.
Harkaway PS; Conlon PF; Hirsh JD; Allen WT
J Clin Pharmacol; 1985 Sep; 25(6):444-7. PubMed ID: 4056079
[TBL] [Abstract][Full Text] [Related]
38. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
Eichhorn J; Perré R
Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
[No Abstract] [Full Text] [Related]
39. [Levels of blood theophylline in patients with acute bronchospasm].
Martínez MJ; Martínez B; Saucedo R; García Delgado R; García Morillas M; Puche E
Rev Clin Esp; 1989 May; 184(9):470-2. PubMed ID: 2772324
[TBL] [Abstract][Full Text] [Related]
40. [Tolerance and effect of short-term theophylline infusions].
Schmidt M
Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
